Asia has a significantly greater prevalence of Cholangiocarcinoma, in comparison to the other parts of the world, with China, South Korea, Thailand, and Taiwan having the highest incidence rates in the region.
Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published
Read more